Xeljanz Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

White round immediate release film-coated tablet (5 mg tablet).
Each 5 mg film-coated tablet contains 8.078 mg of tofacitinib citrate equivalent to 5 mg of tofacitinib free base active pharmaceutical ingredient.
Tofacitinib citrate (CP-690,550-10) has a molecular weight of 504.5 Daltons, or 312.4 Daltons, for tofacitinib free base (CP-690,550). The molecular formula of tofacitinib citrate is C₁₆H₂₀N₆O·C₆H₈O₇.
Excipients with known effect: Each 5 mg tablet also contains 62.567 mg lactose monohydrate.
Excipients/Inactive Ingredients: Microcrystalline cellulose, Lactose monohydrate, Croscarmellose sodium, Magnesium stearate.
Film Coat for 5 mg tablets: Opadry II White (33G28523) containing: HPMC 2910/Hypromellose 6cP, Titanium dioxide, Lactose monohydrate, Macrogol/PEG3350, Triacetin (glycerol triacetate).

tofacitinib

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma